| 11/1/2011 | CVLM | Millipore calls 3.75% convertibles; noteholders may put, convert notes
|
| 12/7/2010 | BKCVHYIG | S&P lifts Millipore from junk
|
| 10/28/2010 | CVIG | S&P ups Millipore notes to BBB+
|
| 10/27/2010 | BKCVHY | Moody's lifts Millipore notes
|
| 10/13/2010 | BKCVHY | Moody's: Millipore notes may rise
|
| 7/27/2010 | CVHYLM | Millipore 3.75%, 5.875% noteholders get change-of-control put option
|
| 7/16/2010 | CV | Millipore holders may convert 3.75% notes following Merck acquisition
|
| 7/15/2010 | CVLM | Millipore amends 3.75% convertible notes following acquisition; holders may put back 5 7/8% notes
|
| 6/9/2010 | CV | Millipore's 3.75% convertible notes to become convertible on June 14
|
| 3/2/2010 | BKCVHY | S&P affirms Millipore; outlook positive
|
| 3/1/2010 | CV | Market Commentary: Millipore a little weaker dollar neutral, but OSI Pharma expands; Amylin, Isis also in trade
|
| 2/22/2010 | CV | Market Commentary: Millipore higher on potential takeout reports; Seagate steady; Trico Marine heads still lower
|
| 10/16/2008 | SS | Blue Ridge reports 5.47% passive stake in Millipore
|
| 11/10/2006 | BT | Merrill reinstates Millipore at buy
|
| 9/28/2006 | BKDDHY | Moody's introduces new ratings
|
| 9/22/2006 | CV | Market Commentary: Priceline climbs on debut; Lions Gate jumps on stock upgrade; Novell steady amid looming default
|
| 7/17/2006 | BKBTCVHY | Moody's cuts Millipore to junk
|
| 6/28/2006 | BKBTCVHY | Moody's rates Millipore notes Ba2
|
| 6/23/2006 | BTHY | New Issue: Millipore prices €250 million 10-year notes to yield Bunds plus 200 bps
|
| 6/23/2006 | CV | Market Commentary: Convertibles mostly quiet; Six Flags drops outright, new MedImmune issues lifted 1 point
|
| 6/23/2006 | HY | Market Commentary: Petrohawk, Stone Energy lead pricing parade; Six Flags falls on warning, ratings moves
|
| 6/22/2006 | HY | Market Commentary: Adelphia bonds jump on inter-creditor progress; Hilcorp deal prices; funds see $418 million outflow
|
| 6/22/2006 | BTHY | Millipore €250 million 10-year notes talked at Bunds plus 200 bps, may price Friday
|
| 6/21/2006 | BKBTHY | S&P assigns Millipore notes BBB-
|
| 6/20/2006 | BTHY | Millipore shopping split-rated €250 million 10-year senior notes
|
| 6/20/2006 | BT | Market Commentary: Discovery Labs bounces; Biomira looks for acquisitions; Curis hits new low; Human Genome higher
|
| 6/20/2006 | HY | Market Commentary: TransDigm, downsized International Coal deals price; GM off on ratings downgrades
|
| 6/8/2006 | BKBTHY | S&P rates Millipore notes BB-
|
| 6/7/2006 | CV | Market Commentary: Interpublic, Spansion, Charles River climb, Millipore struggles on debuts; Level 3 up in gray; L-3 gains
|
| 6/7/2006 | BTCV | New Issue: Millipore prices $550 million 20-year convertibles within talk, at 3.75%, up 40%
|
| 6/7/2006 | BKBTHY | S&P assigns Millipore loan BBB-
|
| 6/7/2006 | BT | Market Commentary: Antigenics up 11% on data; Discovery Labs dives 19%; Incyte up; VaxGen slides
|
| 6/6/2006 | BT | Market Commentary: Xenoport deal emerges; Human Genome up 4%; Anadys, Idenix drop on HGSI news; Onyx up
|
| 6/6/2006 | CV | Market Commentary: New deals seen as unexciting; Spansion structure seen as too long; Charles River, Millipore views mixed
|
| 6/6/2006 | BTCV | Millipore's $550 million of 20-year convertibles talked 3.25%-3.75%, up 37.5%-42.5%, to price Tuesday
|
| 6/6/2006 | BK | Millipore $250 million term loan expected at Libor plus 137.5 bps
|
| 6/1/2006 | BKBTHY | S&P cuts Millipore to junk
|
| 5/30/2006 | BKHY | Millipore acquisition financing to include $750 million term debt, $400 million bridge loan
|
| 4/27/2006 | BKBTHY | Moody's may downgrade Millipore
|
| 4/26/2006 | BT | Millipore at neutral by Merrill
|
| 4/26/2006 | BT | Market Commentary: Inspire trial launch brings buyers; Avigen players hopeful; Applera units mixed; LifeCell lifted 15%
|
| 4/25/2006 | BKBTHY | S&P puts Serologicals on positive watch, Millipore on negative watch
|
| 4/25/2006 | BT | Millipore to acquire Serologicals in all-cash deal worth $1.4 billion
|
| 4/25/2006 | BT | Market Commentary: Serologicals, Millipore both up; other services names dip; DOV, Discovery dive; Neurocrine off
|
| 4/25/2006 | BKBT | Millipore plans approximately $900 million of new debt for Serologicals purchase
|
| 2/14/2006 | BKBTHY | Moody's upgrades Millipore
|
| 1/30/2006 | BT | Merrill gives Millipore neutral rating
|
| 11/1/2005 | BKHY | Moody's may upgrade Millipore
|
| 11/1/2005 | BT | Moody's may raise Millipore
|
| 10/26/2005 | BT | Merrill Lynch keeps Millipore at neutral
|
| 7/20/2005 | BT | Millipore cut by Merrill Lynch to neutral
|
| 7/7/2005 | BT | Millipore unchanged, but Merrill evaluating
|
| 7/7/2005 | BT | Market Commentary: Accentia delays IPO on positive news; Salix takes off; Millipore gains; Sepracor off; Amgen soars
|
| 7/6/2005 | BT | Millipore retained by Merrill at buy
|
| 6/30/2005 | BT | Millipore upgraded by Thomas Weisel
|
| 6/30/2005 | BT | Millipore price target upped by Merrill Lynch
|
| 6/30/2005 | BT | Market Commentary: Elan shares move up, credit lags, Connetics rises against the tide; Medicis, Inamed up; Millipore off
|
| 1/23/2004 | HY | Moody's revises Millipore outlook to positive
|
| 10/22/2003 | BKHY | Moody's cuts Insight
|
| 9/28/2001 | HY | S&P revises Nexstar Broadcasting outlook revised to negative
|
